Effect of S-Adenosyl Methionine Treatment on Recurrence After Curative Resection of Hepatocellular Carcinoma
NCT02586285 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 300
Last updated 2016-04-01
Summary
The aim of this study is to explore the effect of S-Adenosyl Methionine on recurrence after curative resection of Hepatocellular Carcinoma.
Conditions
Interventions
- DRUG
-
S-Adenosyl Methionine
500mg-1000mg,iv,qd
Sponsors & Collaborators
-
Eastern Hepatobiliary Surgery Hospital
lead OTHER
Principal Investigators
-
Shen Feng, MD · Eastern Hepatobiliary Surgery Hospital, Second Military Medical University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-06-30
- Primary Completion
- 2017-12-31
- Completion
- 2017-12-31
Countries
- China
Study Locations
More Related Trials
-
Allogene MSCs Transplantation in Patients With Chronic Liver Diseases Through Peripheral Vein.
NCT01256125 ·Status: UNKNOWN
-
Sorafenib Tosylate and Chemoembolization in Treating Patients With Unresectable Liver Cancer
NCT01042041 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase III Study of AK104 as Adjuvant Therapy in HCC With High Risk of Recurrence After Curative Resection
NCT05489289 ·Status: RECRUITING ·Phase: PHASE3
-
A Randomized, Double-Blinded, Placebo-Controlled Study of Sorafenib in Patients With Advanced Hepatocellular Carcinoma
NCT00492752 ·Status: COMPLETED ·Phase: PHASE3
-
Capecitabine to Prevent Recurrence of Hepatocellular Carcinoma After Curative Resection
NCT00561522 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Efficacy and Safety of Donafenib in Patients With Advanced Hepatocellular Carcinoma
NCT02645981 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Single-arm Clinical Study of HAIC Combined With Apatinib and Camrelizumab in the Treatment of Unresectable MTM HCC
NCT05839197 ·Status: RECRUITING ·Phase: PHASE2
-
Precision Cell Immunotherapy Combined With TACE in Advanced Liver Cancer
NCT02862587 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Anti-recurrence Treatment of Postresection on HCC Patients With MVI Presence and Over-expression of ASPH
NCT02587884 ·Status: UNKNOWN ·Phase: PHASE1
-
Radiofrequency Ablation Combined With S-1 for Pancreatic Cancer With Liver Metastasis
NCT02634502 ·Status: UNKNOWN ·Phase: PHASE2
-
Sorafenib and TACE as Adjuvant Therapy for MVI in HCC Patients After Radical Resection
NCT02537158 ·Status: UNKNOWN ·Phase: NA
-
Study of Thymopentin in Patients After Curative Resection of Small Hepatocellular Carcinoma
NCT00460681 ·Status: UNKNOWN ·Phase: PHASE3
-
A Study of Vitamin C in the Treatment of Liver Cancer to Determine if it is Safe and Effective
NCT01754987 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Postoperative Adjuvant Therapy of Donafenib for Hepatocellular Carcinoma
NCT06581315 ·Status: RECRUITING ·Phase: NA
-
Chemotherapy Combined With Adebrelimab and Apatinib as the Perioperative Treatment in Patients With Biliary Tract Cancer
NCT06280508 ·Status: RECRUITING ·Phase: PHASE2
-
S-1 in Combination With Abraxane in Treating Cholangiocarcinoma
NCT01963325 ·Status: COMPLETED ·Phase: PHASE2
-
Adjuvant Chemotherapy Based on the Adenosine Triphosphate Tumor Chemosensitivity Assay for Hepatocellular Carcinoma After Liver Transplantation
NCT02580253 ·Status: WITHDRAWN ·Phase: PHASE2
-
A Study of Capecitabine Versus S-1 as Adjuvant Therapy in Patients With Biliary Tract Carcinoma After Surgical Resection
NCT04856761 ·Status: UNKNOWN
-
A Trial to Compare Surgery With Sorafenib for Hepatic Celluler Cancer With Portal Vein Tumor Thrombosis
NCT03178656 ·Status: UNKNOWN ·Phase: PHASE4
-
Radiofrequency Ablation Combined With Recombinant Human Adenovirus Type 5 in the Treatment of Hepatocellular Carcinoma.
NCT03790059 ·Status: UNKNOWN ·Phase: NA
-
Chemoembolization With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery
NCT01004978 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Hepatectomy on the Prognosis of Patients With Nasopharyngeal Carcinoma Liver Metastases
NCT05771025 ·Status: RECRUITING ·Phase: NA
-
Treatment of Avatrombopag for Thrombocytopenia in Patients Undergoing Selective Resection of Hepatocellular Carcinoma
NCT05087459 ·Status: UNKNOWN
-
SCT-I10A Plus SCT510 Versus Sorafenib as First-Line Therapy for Advanced Hepatocellular Carcinoma
NCT04560894 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3
-
A Study of the Effectiveness and Safety of AMG 386 and Sorafenib to Treat Advanced or Inoperable Hepatocellular Cancer
NCT00872014 ·Status: COMPLETED ·Phase: PHASE2